Details for Patent: 8,192,719
✉ Email this page to a colleague
Which drugs does patent 8,192,719 protect, and when does it expire?
Patent 8,192,719 protects MACRILEN and is included in one NDA.
This patent has eleven patent family members in ten countries.
Summary for Patent: 8,192,719
| Title: | Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds |
| Abstract: | A method of assessing growth hormone deficiency in a human or animal subject, the method comprising administering orally to the subject EP 1572 (Formula I) or EP 1573 (Formula II), obtaining a post-administration sample from the subject, determining the level of growth hormone in the sample and assessing whether the level of growth hormone in the sample is indicative of growth hormone deficiency in the subject. Preferably, the GH level in the sample is measured by immunoassay. Also disclosed is a kit of parts constituting a diagnostic kit comprising: (a) EP 1572 or EP 1573 formulated for oral administration; and (b) means for determining the level of growth hormone in a sample. |
| Inventor(s): | Larsen; Finn (Edinburgh, GB) |
| Assignee: | Aeterna Zentaris GmbH (Frankfurt, DE) |
| Application Number: | 12/279,805 |
|
Patent Claim Types: see list of patent claims | Use; Device; Dosage form; |
Drugs Protected by US Patent 8,192,719
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD FOR THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY BY MEASURING THE LEVEL OF GROWTH HORMONE AFTER ORAL ADMINISTRATION OF MACIMORELIN | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,192,719
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0603295.7 | Feb 18, 2006 |
| PCT Information | |||
| PCT Filed | February 19, 2007 | PCT Application Number: | PCT/GB2007/000566 |
| PCT Publication Date: | August 23, 2007 | PCT Publication Number: | WO2007/093820 |
International Family Members for US Patent 8,192,719
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Cyprus | 1115080 | ⤷ Try a Trial | |||
| Denmark | 1984744 | ⤷ Try a Trial | |||
| European Patent Office | 1984744 | ⤷ Try a Trial | |||
| Spain | 2404582 | ⤷ Try a Trial | |||
| United Kingdom | 0603295 | ⤷ Try a Trial | |||
| Japan | 2009526989 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
